• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ivabradine for systolic heart failure.

作者信息

Meade Courtney M, Clements Jennifer N

机构信息

At the time this article was written, Courtney M. Meade was a student in the Presbyterian College School of Pharmacy in Clinton, S.C. Jennifer N. Clements is associate professor of pharmacy practice in the Presbyterian College School of Pharmacy. The authors have disclosed no potential conflicts of interest, financial or otherwise.

出版信息

JAAPA. 2018 Mar;31(3):52-54. doi: 10.1097/01.JAA.0000530305.69021.02.

DOI:10.1097/01.JAA.0000530305.69021.02
PMID:29470374
Abstract

Ivabradine works in the sinoatrial node to prolong diastolic depolarization and reduce heart rate. In patients with chronic systolic heart failure, this drug has reduced the risk of hospitalization when used in combination with other optimal pharmacotherapy.

摘要

相似文献

1
Ivabradine for systolic heart failure.
JAAPA. 2018 Mar;31(3):52-54. doi: 10.1097/01.JAA.0000530305.69021.02.
2
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.依伐布雷定降低心力衰竭患者心率对结局的影响:β受体阻滞剂剂量是否有影响?SHIFT(伊伐布雷定治疗收缩性心力衰竭试验)研究的结果。
J Am Coll Cardiol. 2012 May 29;59(22):1938-45. doi: 10.1016/j.jacc.2012.01.020.
3
Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease.伊伐布雷定使收缩性心力衰竭合并冠状动脉疾病患者心率减慢的益处。
Am J Cardiol. 2016 Dec 15;118(12):1948-1953. doi: 10.1016/j.amjcard.2016.08.089. Epub 2016 Sep 15.
4
Ivabradine in heart failure--no paradigm SHIFT…yet.伊伐布雷定用于心力衰竭——尚未出现范式转变……目前还没有。
Lancet. 2010 Sep 11;376(9744):847-9. doi: 10.1016/S0140-6736(10)61314-1.
5
[Correction of sinus rate by inhibitors of If-channels in patients with acute decompensated heart failure].[急性失代偿性心力衰竭患者中If通道抑制剂对窦性心律的校正作用]
Kardiologiia. 2014;54(11):34-8.
6
The effects of ivabradine on left atrial electromechanical function in patients with systolic heart failure.伊伐布雷定对收缩性心力衰竭患者左心房机电功能的影响。
J Interv Card Electrophysiol. 2016 Sep;46(3):253-8. doi: 10.1007/s10840-016-0129-2. Epub 2016 Apr 2.
7
Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial).心血管和非心血管合并症对伊伐布雷定降低心率治疗稳定型心力衰竭的疗效及预后的影响(来自SHIFT试验)
Am J Cardiol. 2015 Dec 15;116(12):1890-7. doi: 10.1016/j.amjcard.2015.09.029. Epub 2015 Oct 9.
8
Effect of ivabradine on numbers needed to treat for the prevention of recurrent hospitalizations in heart failure patients.伊伐布雷定对心力衰竭患者预防再次住院所需治疗人数的影响。
Curr Med Res Opin. 2015;31(10):1903-9. doi: 10.1185/03007995.2015.1080155. Epub 2015 Sep 11.
9
Ivabradine in Severe Aortic Stenosis with Poor Left Ventricular Ejection Fraction.
J Heart Valve Dis. 2015 Jul;24(4):433-5.
10
Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study.SHIFT 研究:慢性心力衰竭和慢性阻塞性肺疾病患者的临床特征和结局:疗效和安全性分析。
Int J Cardiol. 2013 Dec 10;170(2):182-8. doi: 10.1016/j.ijcard.2013.10.068. Epub 2013 Oct 25.